MWP
TEVA icon

Meridian Wealth Partners’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Meridian Wealth Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-211
Closed -$2K – 1133
2021
Q1 		$2K Buy
+211
New +$2.42K ﹤0.01% 1050

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Meridian Wealth Partners's TEVA Position: Q2 2021 in Review

Meridian Wealth Partners sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2021, closing a stake of 211 shares — an estimated $2K sold.

Meridian Wealth Partners first reported a position in TEVA in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 440 funds tracked by Wall St. Rank hold TEVA as of Q2 2021.

  • Meridian Wealth Partners reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2021 after selling out during the quarter.
  • Meridian Wealth Partners sold 211 Teva Pharmaceutical Industries Limited shares in Q2 2021, an estimated $2K.
  • Meridian Wealth Partners first reported a position in Teva Pharmaceutical Industries Limited in Q1 2021 and held it in 1 quarter.
  • Meridian Wealth Partners's Teva Pharmaceutical Industries Limited position peaked at $2K in Q1 2021.
  • 440 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2021.

Based on Meridian Wealth Partners's 13F filing for Q2 2021, filed 12 Aug 2021.